clinical

Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinsons Disease

Event to be held October 14th at 4 p.m. EST October 09, 2025 07:00 ET  | Source: Gain Therapeutics, Inc.…

6 days ago

ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization

Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography…

1 week ago

Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer

Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research OrganizationsLONDON--(BUSINESS…

1 week ago

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease

Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…

1 week ago

HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease

HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by The Hong Kong University of Science and Technology…

1 week ago

New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk

MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical…

2 weeks ago

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and clinical research transformation. CAMBRIDGE, Mass.,…

2 weeks ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

2 weeks ago

Integrated Dermatology Welcomes Experienced Dermatology PA Kinston Cummings to Lake Dermatology Medical Associates in California

BOCA RATON, Fla.--(BUSINESS WIRE)--#Dermatology--Integrated Dermatology, the country’s largest independent dermatology provider, is pleased to welcome Kinston Cummings, PA-C, to the…

3 weeks ago

MindHYVE.ai Unveils ChironAI: The World’s First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence

NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an…

3 weeks ago